Drs. Modi, Kaden, and Read will provide valuable guidance on utilizing imaging techniques and biomarkers to identify patients with geographic atrophy (GA) who need timely referral to a retina specialist. They will also review the efficacy and safety data of the two approved GA therapies, enabling you to confidently educate your patients.
This activity is supported by unrestricted educational grants from Astellas and Carl Zeiss Meditec.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
Sponsored by 
This activity, COPE Activity Number 129574, is accredited by COPE for continuing education for optometrists. This course is approved for 1 hour of CE.
Course #: 94443-TD
Activity #: 129574
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Yasha S. Modi, MD, MHS
Associate Professor of Ophthalmology
Department of Ophthalmology
Director of Tele-Retina
NYU Langone Health
New York, NY
Talia R. Kaden, MD
Assistant Professor of Ophthalmology
Fellowship Program Director
Manhattan Eye, Ear, & Throat Hospital
Northwell Health
New York, NY
Sarah Parker Read, MD, PhD
Retina Consultants of Hawaii
Honolulu, HI
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Yasha S. Modi, MD, MHS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie/Allergan, Alcon, Apellis Pharmaceuticals, Astellas, Carl Zeiss Meditec, EyePoint Pharmaceuticals, Genentech, Neurotech, Notal Vision, Opthea, Regeneron, and Topcon. Grant/Research Support: Genentech.
Talia R. Kaden, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Alimera Sciences, Genentech, and Regeneron.
Sarah Parker Read, MD, PhD, has had no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners, and reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Astellas, or Carl Zeiss Meditec.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
1.00 creditKathleen N. Moore, MD, MS, FASCO
Aaron Samuel Gold, OD, FAAO
Carlo J. Pelino, OD, FAAO
Kathleen N. Moore, MD, MS, FASCO
Kamran M. Riaz, MD
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
